These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 25547711)
1. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711 [TBL] [Abstract][Full Text] [Related]
2. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression. Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220 [TBL] [Abstract][Full Text] [Related]
3. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial. Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424 [TBL] [Abstract][Full Text] [Related]
4. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging. Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427 [TBL] [Abstract][Full Text] [Related]
5. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Shilyansky C; Williams LM; Gyurak A; Harris A; Usherwood T; Etkin A Lancet Psychiatry; 2016 May; 3(5):425-35. PubMed ID: 26995298 [TBL] [Abstract][Full Text] [Related]
6. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial. Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420 [TBL] [Abstract][Full Text] [Related]
7. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report. Braund TA; Palmer DM; Williams LM; Harris AWF Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398 [TBL] [Abstract][Full Text] [Related]
8. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression. Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798 [TBL] [Abstract][Full Text] [Related]
9. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial. Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM Trials; 2013 Jul; 14():224. PubMed ID: 23866851 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial. Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399 [TBL] [Abstract][Full Text] [Related]
11. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419 [TBL] [Abstract][Full Text] [Related]
12. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E Trials; 2011 Jan; 12():4. PubMed ID: 21208417 [TBL] [Abstract][Full Text] [Related]
13. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report. van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359 [TBL] [Abstract][Full Text] [Related]
14. Heart rate variability as a biomarker of anxious depression response to antidepressant medication. Kircanski K; Williams LM; Gotlib IH Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742 [TBL] [Abstract][Full Text] [Related]
15. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212 [TBL] [Abstract][Full Text] [Related]
16. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report. Braund TA; Palmer DM; Williams LM; Harris AW Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405 [TBL] [Abstract][Full Text] [Related]
17. Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression. Maller JJ; Broadhouse K; Rush AJ; Gordon E; Koslow S; Grieve SM Mol Psychiatry; 2018 Aug; 23(8):1737-1744. PubMed ID: 29133948 [TBL] [Abstract][Full Text] [Related]
18. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792 [TBL] [Abstract][Full Text] [Related]
19. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity. Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100 [TBL] [Abstract][Full Text] [Related]
20. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome? Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]